Annual EBIT
-$102.78 M
-$50.21 M-95.53%
December 31, 2023
Summary
- As of February 7, 2025, GPCR annual earnings before interest & taxes is -$102.78 million, with the most recent change of -$50.21 million (-95.53%) on December 31, 2023.
- During the last 3 years, GPCR annual EBIT has fallen by -$86.87 million (-546.14%).
- GPCR annual EBIT is now -546.14% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
GPCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$45.84 M
-$12.52 M-37.58%
September 30, 2024
Summary
- As of February 7, 2025, GPCR quarterly earnings before interest & taxes is -$45.84 million, with the most recent change of -$12.52 million (-37.58%) on September 30, 2024.
- Over the past year, GPCR quarterly EBIT has dropped by -$19.69 million (-75.31%).
- GPCR quarterly EBIT is now -261.11% below its all-time high of -$12.69 million, reached on September 30, 2022.
Performance
GPCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$142.16 M
-$19.69 M-16.08%
September 30, 2024
Summary
- As of February 7, 2025, GPCR TTM earnings before interest & taxes is -$142.16 million, with the most recent change of -$19.69 million (-16.08%) on September 30, 2024.
- Over the past year, GPCR TTM EBIT has dropped by -$57.42 million (-67.77%).
- GPCR TTM EBIT is now -970.97% below its all-time high of -$13.27 million, reached on December 1, 2021.
Performance
GPCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GPCR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.5% | -75.3% | -67.8% |
| 3 y3 years | -546.1% | -75.3% | -67.8% |
| 5 y5 years | -546.1% | -75.3% | -67.8% |
GPCR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -172.6% | at low | -261.1% | at low | -971.0% | at low |
| 5 y | 5-year | -546.1% | at low | -261.1% | at low | -971.0% | at low |
| alltime | all time | -546.1% | at low | -261.1% | at low | -971.0% | at low |
Structure Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$45.84 M(+37.6%) | -$142.16 M(+16.1%) |
| Jun 2024 | - | -$33.32 M(+4.1%) | -$122.47 M(+6.4%) |
| Mar 2024 | - | -$32.02 M(+3.3%) | -$115.14 M(+12.0%) |
| Dec 2023 | -$102.78 M(+95.5%) | -$30.99 M(+18.5%) | -$102.78 M(+21.3%) |
| Sep 2023 | - | -$26.14 M(+0.6%) | -$84.74 M(+18.9%) |
| Jun 2023 | - | -$25.99 M(+32.3%) | -$71.28 M(+20.3%) |
| Mar 2023 | - | -$19.65 M(+51.7%) | -$59.26 M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$52.56 M(+39.4%) | -$12.96 M(+2.1%) | -$52.56 M(-0.6%) |
| Sep 2022 | - | -$12.69 M(-9.1%) | -$52.88 M(+31.6%) |
| Jun 2022 | - | -$13.96 M(+7.8%) | -$40.19 M(+53.2%) |
| Mar 2022 | - | -$12.95 M(-2.4%) | -$26.23 M(+97.6%) |
| Dec 2021 | -$37.70 M(+137.0%) | - | - |
| Dec 2021 | - | -$13.27 M | -$13.27 M |
| Dec 2020 | -$15.91 M | - | - |
FAQ
- What is Structure Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Structure Therapeutics?
- What is Structure Therapeutics annual EBIT year-on-year change?
- What is Structure Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Structure Therapeutics?
- What is Structure Therapeutics quarterly EBIT year-on-year change?
- What is Structure Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Structure Therapeutics?
- What is Structure Therapeutics TTM EBIT year-on-year change?
What is Structure Therapeutics annual earnings before interest & taxes?
The current annual EBIT of GPCR is -$102.78 M
What is the all time high annual EBIT for Structure Therapeutics?
Structure Therapeutics all-time high annual earnings before interest & taxes is -$15.91 M
What is Structure Therapeutics annual EBIT year-on-year change?
Over the past year, GPCR annual earnings before interest & taxes has changed by -$50.21 M (-95.53%)
What is Structure Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of GPCR is -$45.84 M
What is the all time high quarterly EBIT for Structure Therapeutics?
Structure Therapeutics all-time high quarterly earnings before interest & taxes is -$12.69 M
What is Structure Therapeutics quarterly EBIT year-on-year change?
Over the past year, GPCR quarterly earnings before interest & taxes has changed by -$19.69 M (-75.31%)
What is Structure Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of GPCR is -$142.16 M
What is the all time high TTM EBIT for Structure Therapeutics?
Structure Therapeutics all-time high TTM earnings before interest & taxes is -$13.27 M
What is Structure Therapeutics TTM EBIT year-on-year change?
Over the past year, GPCR TTM earnings before interest & taxes has changed by -$57.42 M (-67.77%)